loading...

Evolution of IL-23 inhibitors for Crohn’s disease management

  • Gastroenterology
  • webinar

Event

Evolution of IL-23 inhibitors for Crohn’s disease management

Period

9 Mar 2022 - 9 Mar 2022

Speaker

Silvio Danese, Italy - Laurent Peyrin-Biroulet, France - Subrata Ghosh, Ireland - Peter Irving, UK
Download the program

The evolution of biological drugs has made major steps forwards for the treatment of IBD. Among these biologicals are the IL-23 inhibitors for which new agents as well as new data on monoclonal antibodies are becoming available for the treatment of CD.